Synthesis and Bioactivity Evaluation of Nepetaefolin F and Its Analogues.
Xu-Dong MaoTing-Ting DuQi GuLi YangHai-Lian ShiRan HongGui-Xin Chou WeiPublished in: ACS omega (2023)
Nepetaefolin F ( 5 ), an abietane diterpenoid, showed significant inhibitory activity against human cancer cells in vitro with an IC 50 value of 6.3 μM. The syntheses of nepetaefolin F and its analogues are presented herein. The cytotoxicity against various cancer cell lines was evaluated; notably, the cyclopropanecarboxylate ester 42 displayed significant antitumor activity against MGC 803 cells with an IC 50 value of 20.9 μM. Further studies revealed that 42 could upregulate the expression of p62, microtubule-associated protein 1 light-chain 3 β (LC3 B-I), cleaved caspase-3, and cleaved caspase-9 and downregulate the expression of Beclin-1 and LC3B-II. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that 42 could modulate multiple signaling pathways, especially for peroxisome proliferator-activated receptor (PPAR) and AMP-activated protein kinase (AMPK), which are closely related to autophagy. These results suggested that compound 42 is a promising lead by inhibiting cell proliferation and autophagy, as inducing cell apoptosis in MGC 803 cells.
Keyphrases
- induced apoptosis
- signaling pathway
- endoplasmic reticulum stress
- cell death
- cell cycle arrest
- protein kinase
- cell proliferation
- oxidative stress
- pi k akt
- poor prognosis
- epithelial mesenchymal transition
- endothelial cells
- binding protein
- papillary thyroid
- skeletal muscle
- genome wide
- lymph node metastasis
- long non coding rna
- single cell
- type diabetes
- squamous cell carcinoma
- fatty acid
- bioinformatics analysis
- genome wide identification
- high resolution mass spectrometry